[1] 中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆).中华消化杂志,2013,33:581-592.
[2] Blei AT, Córdoba J; Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol, 2001, 96: 1968-1976.
[3] 赵凯,张跃新.轻微肝性脑病的治疗现状.临床肝胆病杂志,2014,30:1094-1096.
[4] Lauridsen MM, Jepsen P, Vilstrup H. Critical nicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with 1iver disease. Metab Brain Dis, 2011, 26: 135-139.
[5] Weissenborn K. The Clinical Relevance of Minimal Hepatic Encephalopathy-A Critical Look. Dig Dis, 2015, 33: 555-561.
[6] Mullen KD, Prakash RK. Management of covert hepatic encephalopathy. Clin Liver Dis, 2012, 16: 91-93.
[7] Kappus MR, Bajaj JS. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests). Clin Liver Dis, 2012, 16: 43-55.
[8] Conn HO. Trail making and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis, 1977, 22: 541-550.
[9] Zhong BH, Chen H, Wang JH, et al. The value of number connection test in the diagnosis of sub-clinical hepatic encephalopathy. Chin J Intern Med, 2001, 40:13-15.
[10] Hao LC, Hu YQ, Hou XH. Age-and, education-corrected number connection test and digit symbol test in diagnosis of minimal hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi, 2015, 23: 533-537.
[11] Karantzoulis S1, Novitski J, Gold M, et al. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Arch Clin Neuropsychol, 2013, 28: 837-844.
[12] Gupta D, Ingle M, Shah K, et al. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. J Dig Dis, 2015, 16: 400-407.
[13] Lauridsen MM, Thiele M, Kimer N, et al. The continuous reaction times method for diagnosing, grading,and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis, 2013, 28: 231-234.
[14] Lauridsen MM, Schaffalitzky de Muckadell OB, Vilstrup H. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis, 2015, 30: 1187-1192.
[15] Lauridsen MM, Poulsen L, Rasmussen CK, et al. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy. Metab Brain Dis, 2015.
[16] 何润莲,杨晋辉.轻微型肝性脑病诊断研究进展.实用肝脏病杂志,2014,17:325-328.
[17] 林言,范燕萍,余建军,等.诱发电位对肝硬化患者轻微肝性脑病的诊断价值.中华消化杂志,2010, 30: 444-447.
[18] 王月,石绣江,希尔娜依·阿不都黑力力,等.临界闪烁频率诊断轻微肝性脑病的价值.中华肝脏病杂志,2013, 21:546-547.
[19] Ampuero J, Simón M, Montoliú C, et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology, 2015, 149: 1483-1489.
[20] Meng LP, Chen YC, Li YH, et al. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity. Eur J Radiol, 2015, 84: 2019-2023.
[21] Qi R, Zhang LJ, Chen HJ, et al. Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy. Sci Rep, 2015, 5: 13720.
[22] Felipo V, Urios A, Giménez-Garzó C, et al. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests. World J Gastroenterol, 2014, 20: 11815-11825.
[23] Barbosa M, Marinho C, Mota P, et al. Minimal hepatic encephalopathy: the reality beyond our eyes, Acta Med Port, 2015, 28: 480-485.
[24] Ong JP, Aggarwal A, Krieger D, et a1. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med, 2003, 114: 188-193.
[25] Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol, 2001, 96: 1968-1976.
[26] Arias N, Méndez M, Gómez-Lázaro E, et al. Main target of minimal hepatic encephalopathy: morphophysiological, inflammatory and metabolic view. Physiol Behav, 2015, 149: 247-254.
[27] Montoliu C, Cauli O, Urios A, et a1. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol, 2011, 106: 1629-1637.
[28] 翟慧勤,范红,耿嘉蔚,等.轻微型肝性脑病患者的肠道微生物群和血浆内毒素水平.中华肝脏病杂志,2014,22:104-107. |
